Therefore, we further explored the effects of the F11R gene on the malignant biological behavior of pancreatic cancer cells by knocking down the F11R gene and establishing a negative control group, laying a foundation for future molecular pathway research. This evidence concerns the gene F11R and familial pancreatic carcinoma.